David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.73% |
| 2 | Technology | 18.6% |
| 3 | Consumer Discretionary | 9.12% |
| 4 | Healthcare | 7.62% |
| 5 | Industrials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Strategic Education
STRA
$1.91B
| $4.03M | ﹤0.01% |
50,212
-33,391
| -40% | -$2.67M |
|
2377
Navitas Semiconductor
NVTS
$3.14B
| $4.03M | ﹤0.01% |
563,853
-329,996
| -37% | -$3.18M |
|
2378
BioLife Solutions
BLFS
$1.8B
| $4.02M | ﹤0.01% |
166,381
-119,162
| -42% | -$3.12M |
|
2379
Sempra
SRE
$56.5B
| $4.01M | ﹤0.01% |
45,439
+907
| +2% | +$82.6K |
|
|
HDSN
2380
Hudson Technologies
HDSN
$229M
| $3.99M | ﹤0.01% |
582,780
-239,029
| -29% | -$1.88M |
|
2381
Liquidity Services
LQDT
$1.29B
| $3.99M | ﹤0.01% |
131,688
+85,290
| +184% | +$2.29M |
|
2382
Loews
L
$22.5B
| $3.99M | ﹤0.01% |
37,860
-53,541
| -59% | -$5.53M |
|
2383
Global X Cybersecurity ETF
BUG
$1.54B
| $3.99M | ﹤0.01% |
130,842
+122,335
| +1,438% | +$4.05M |
|
2384
Usana Health Sciences
USNA
$265M
| $3.98M | ﹤0.01% |
202,586
+152,016
| +301% | +$3.15M |
|
2385
SiriusPoint
SPNT
$2.81B
| $3.97M | ﹤0.01% |
181,476
-111,514
| -38% | -$2.24M |
|
2386
Chewy
CHWY
$9.54B
| $3.97M | ﹤0.01% |
120,003
+13,544
| +13% | +$470K |
|
2387
PUT
Helmerich & Payne
HP
$4.22B
| $3.96M | ﹤0.01% |
138,000
-8,100
| -6% | -$215K |
|
2388
GXO Logistics
GXO
$5.5B
| $3.96M | ﹤0.01% |
75,172
-955
| -1% | -$50.2K |
|
2389
Globe Life
GL
$13.5B
| $3.95M | ﹤0.01% |
28,224
-92,104
| -77% | -$12.5M |
|
2390
PUT
PepsiCo
PEP
$192B
| $3.95M | ﹤0.01% |
27,500
-75,500
| -73% | -$11.1M |
|
2391
Clearfield
CLFD
$401M
| $3.95M | ﹤0.01% |
135,376
+645
| +0.5% | +$20.7K |
|
2392
MarineMax
HZO
$1.15B
| $3.94M | ﹤0.01% |
162,694
+126,041
| +344% | +$3.11M |
|
2393
ProFrac Holding
ACDC
$949M
| $3.94M | ﹤0.01% |
1,012,939
+851,940
| +529% | +$3.48M |
|
|
DOCU
2394
CALL
DocuSign
DOCU
$12.4B
| $3.94M | ﹤0.01% |
57,600
-8,600
| -13% | -$595K |
|
|
DFTX
2395
Definium Therapeutics
DFTX
$5.71B
| $3.93M | ﹤0.01% |
293,722
+77,388
| +36% | +$958K |
|
2396
CALL
Akamai
AKAM
$15.7B
| $3.93M | ﹤0.01% |
45,000
-8,300
| -16% | -$683K |
|
2397
PUT
VF Corp
VFC
$5.42B
| $3.92M | ﹤0.01% |
217,000
+135,200
| +165% | +$2.19M |
|
|
HI
2398
DELISTED
Hillenbrand
HI
| $3.92M | ﹤0.01% |
123,475
-293,254
| -70% | -$9.04M |
|
2399
Heron Therapeutics
HRTX
$60.9M
| $3.91M | ﹤0.01% |
3,004,640
-83,852
| -3% | -$104K |
|
2400
Golub Capital BDC
GBDC
$3.4B
| $3.9M | ﹤0.01% |
+287,334
| New | +$3.98M |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.